KFSHRC Detects 276 Fetal Genetic Disorders Through Prenatal Care Saving SAR 360 Million Annually - Middle East Business News and Information
King Faisal Specialist Hospital & Research Centre (KFSHRC) is enhancing prenatal care through innovation and precision medicine. By testing more than 300 genes, KFSHRC has provided early insights to 1,104 pregnant women, preventing 276 genetic disorders and saving the Saudi healthcare system 360 million riyals.
KFSHRC's Preventive Fetal Screening Program identifies genetic risks and ensures targeted care during critical pregnancy stages. Paired with technologies like Next-Generation Sequencing (NGS) and Non-Invasive Prenatal Testing (NIPT), these advancements enhance the precision and safety of prenatal diagnostics, benefiting 1,500 families annually. The Program has expanded its capacity to detect more than 500 additional genetic diseases, equipping families with early insights, reducing the birth of new-borns with severe genetic diseases, and improving overall offspring outcomes and well-being.
From screenings to therapeutic procedures and advanced surgical interventions, KFSHRC ensures well-being and trust remain at its core, shaping a healthier future for families. These efforts were recognised in 2023 when the prenatal department won a Performance Improvement Award for improving the patient experience through care accessibility and innovation.
It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15 th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CairoScene
3 days ago
- CairoScene
Saudi-Emirati Global Fertility Network Acquires HealthPlus in Jeddah
The Saudi-Emirati Global Fertility Network has acquired HealthPlus Fertility Center, rebranding it under Bnoon IVF as part of a $27 million plan to build the region's largest fertility network. Jun 19, 2025 The Saudi-Emirati Global Fertility Network (GFN) has acquired a majority stake in HealthPlus Fertility Center in Jeddah, expanding its presence in Saudi Arabia's growing women's health sector. The facility will be rebranded under the Bnoon IVF name, following GFN's earlier acquisition of Bnoon IVF Center in Riyadh. Together, the two acquisitions represent an investment of over 100 million Saudi Riyals (approximately $27 million), forming the foundation of GFN's strategy to establish the largest fertility care network in Saudi Arabia and the wider GCC. Both HealthPlus and Bnoon IVF previously operated under M42's healthcare portfolio between 2022 and 2024. 'We're seeing a noticeable increase in couples seeking fertility treatment, driven by both primary and secondary infertility,' Dr. Abdulaziz Muhammad AlShahrani, a leading Saudi Reproductive Endocrinology & Infertility (IVF) Consultant, Founder of Bnoon in Riyadh and the Group Medical Director at Bnoon, said. 'With growing awareness, more individuals are also considering fertility treatments to help balance their families and prevent genetic diseases." With these new additions, GFN has doubled its treatment capacity and now conducts more than 5,000 IVF cycles annually, making it the largest standalone provider of assisted reproductive services in the Kingdom. 'We have identified a strong pipe-line of potential targets for acquisition across the region," Majd Abu Zant, Founder and CEO of Global Fertility Network, said. "New IVF facilities are also planned in Khobar, Abha, and additional cities across the Kingdom. With the support of our investment partners, we will continue to rapidly expand our network while introducing cutting-edge technologies faster, enhancing clinical outcomes, and making fertility care more accessible across the region.' GFN is also constructing a 3,800-square-metre flagship centre in northern Riyadh, set to open in December 2025. The facility will focus on advanced fertility treatment and reproductive genetics, and will form part of a broader integrated women's health offering across the network.
Mid East Info
5 days ago
- Mid East Info
Filipino Healthcare Worker Recovers After Removal of Brain Tumor, Nearly the Size of a Tennis Ball, at Aster Hospital Mankhool
A 41-year-old Filipino woman, Ms. Jovelyn Sison Omes, a healthcare assistant at an aesthetic clinic in Dubai, underwent life-saving brain surgery at Aster Hospital, Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025. Ms. Omes had been experiencing severe headaches, nausea, double vision, and a full-body seizure – alarming symptoms that prompted immediate medical evaluation. Upon her admission on November 27, 2024, scans revealed a large, non-cancerous brain tumor on the right side of her brain, known as a falcine meningioma. The tumor had grown across the center of her brain to the opposite side, causing swelling and pressure on critical brain areas, leading to a condition called cerebral edema and mass effect. Dr. Prakash Nair, Consultant Neurosurgeon at Aster Hospital, Mankhool, compared the tumor's size to that of a tennis ball. Despite a medical history of asthma and high cholesterol, Ms. Omes was not on any regular medications. Her symptoms included persistent headaches (VAS 8/10), a seizure with tongue bite, temporary confusion, and a brief episode of double vision. She did not report limb weakness or trauma. On November 28, 2024, Dr. Prakash Nair and his team performed a complex brain surgery on Ms. Jovelyn Sison Omes at Aster Hospital, Mankhool, to remove the tumor located near a critical brain region responsible for limb movement. The patient was placed under general anesthesia, and the surgical team accessed the tumor through four small openings in the skull. Using advanced tools including a state-of-the-art microscope and ultrasonic aspirator (CUSA), the team performed a Simpson Grade 1 resection, meaning the tumor and its roots were entirely removed — significantly lowering the risk of recurrence. Bleeding was controlled without the need for transfusion, and the skull was reconstructed with precision. Following surgery, Ms. Omes was transferred to the ICU and weaned off ventilator support within 24 hours. A follow-up scan confirmed complete tumor removal with no complications. She was mobilized the next day, resumed eating normally within hours, and responded well to physiotherapy. Discharged on December 5, 2024, she made a full recovery with no neurological issues. 'This case highlights the importance of timely diagnosis and advanced neurosurgical care. The tumor was located in a challenging area near vital brain structures, but we were able to remove it completely without causing any damage,' said Dr. Prakash Nair, Consultant Neurosurgeon at Aster Hospital, Mankhool, who led the surgery. He added, 'In cases of Simpson Grade 1 resection, the recurrence rate after 10 years is less than 9%2, which is extremely promising for the patient's long-term prognosis.' Falcine meningiomas make up about 9% of all intracranial meningiomas1 and are more common in women, with a two- to three-fold higher occurrence than in men3. These tumors are typically diagnosed more often with increasing age. In this case, the tumor's fibroblastic subtype added to the complexity of the condition. Ms. Jovelyn Sison Omes expressed her deep gratitude to Dr. Nair and the medical team, saying, 'I'm incredibly thankful to Dr. Nair and the entire team for saving my life. I had been suffering from debilitating symptoms, but today, I'm pain-free, seizure-free, and back to work. As a healthcare worker, I urge everyone not to ignore warning signs. Early intervention truly saved my life, and I hope my story encourages others to seek help when something doesn't feel right. With follow-up imaging confirming a successful outcome and no neurological deficits, Ms. Omes is expected to lead a full and healthy life. Her case stands as a testament to the power of timely diagnosis, surgical expertise, and compassionate care — all hallmarks of Aster Hospital Mankhool's commitment to clinical excellence.
Mid East Info
14-06-2025
- Mid East Info
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies - Middle East Business News and Information
King Faisal Specialist Hospital & Research Centre KFSHRC continues to redefine global healthcare through its Smart Hospital initiative, leveraging AI, simulation, and immersive technologies across its departments. These technologies have supported KFSHRC to enhance workforce training, clinical care, and operational efficiency. The Academic & Training Affairs (ATA) division is leading this transformation, deploying next-generation tools such as simulation labs, e-learning, and virtual reality (VR) to deliver hands-on, immersive training. These technologies allow healthcare professionals to rehearse complex procedures from emergency care to surgical planning, strengthening clinical preparedness and patient safety. The Patient Flow & Capacity Command Centre enhances operational efficiency by applying AI to forecast demand, manage resources, and monitor patient flow in real time. Since its launch, the Centre has completed over 170,000 interventions, cutting bed wait times from 32 to 6 hours and reducing emergency delays by 14%. In 2024 alone, the hospital received over 46,000 new patients and processed more than 79,000 referrals. Smart tools, such as the Noor robot, enhance the patient experience by providing real-time assistance and improving access to services. Across departments such as Radiology, Pathology, Genomics, and Oncology, AI enhances diagnosis, interpretation, early interventions and personalized care for complex diseases. Driving these innovations is KFSHRC's Centre for Healthcare Intelligence (CHI), which has developed over 20 AI applications in medical imaging, clinical decision support, and operations. In partnership with the Saudi Commission for Health Specialties, CHI also leads national AI training programs to build future-ready digital health talent. At the 2024 GAIN Summit CHI unveiled a generative AI platform to synthesize patient data, accelerate diagnostics, and streamline triage. KFSHRC ranks among Saudi Arabia's top 20 government entities in the 2025 Technology Adoption Readiness Index and received the 2024 Zimam Best AI Program Award, recognizing its leadership in AI, robotic surgery, and digital innovation. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings.
